Editorial: Impacts of public-private collaborative research on Alzheimer's disease: the case of the innovative medicines initiative
Main Authors: | Elisabetta Vaudano, Jean Georges, Martin Hofmann-Apitius, Donald Lo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2023.1321225/full |
Similar Items
-
The Innovative Medicines Initiative neurodegeneration portfolio: From individual projects to collaborative networks
by: Diana O'Rourke, et al.
Published: (2022-11-01) -
The European Prevention of Alzheimer's Dementia Programme: An Innovative Medicines Initiative-funded partnership to facilitate secondary prevention of Alzheimer's disease dementia
by: Stina Saunders, et al.
Published: (2022-11-01) -
The pursuit of approaches to federate data to accelerate Alzheimer’s disease and related dementia research: GAAIN, DPUK, and ADDI
by: Arthur W. Toga, et al.
Published: (2023-05-01) -
The Role of Tryptophan Metabolism in Alzheimer’s Disease
by: Karl Savonije, et al.
Published: (2023-02-01) -
Position Statement on Anti-Dementia Medication for Alzheimer’s Disease by Swiss Stakeholders
by: Giovanni B Frisoni, et al.
Published: (2021-08-01)